The Vaccine Choice Canada investigations into Canada’s dual adverse events following immunizations (AEFI) databases began in the winter of 2015. The two separate databases are the Canada Vigilance (CV) database and the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS). The CV database is posted on-line and is touted as searchable by the public. The CAEFISS data is accessible for public scrutiny only through reports released by the Public Health Agency of Canada (PHAC).
The first VCC database report was published in March 2015. An Update Report was published in July of 2015 as new data became available. The third report titled the Vaccine Safety Report, was published in March of 2016 following the receipt of the full CV data for Q1 2015 from MedEffectsTM Canada. This is the fourth report titled, Vaccine Safety Report 2.
We have learned that Canadians deserve far more timely, accessible, accurate and comprehensible data on vaccine-related adverse event reports. Informed consent is impossible without access to this data.
Download your copy below:
Two-page extract from the full 18-page Vaccine Safety Report 2 (PDF)
Vaccine Safety Report 2 (PDF)
Report on the Canada Vigilance Database- What the Public Sees – by Nelle Maxey – April 2015
Update Report on the Canadian Adverse Events Databases by Nelle Maxey – Summer 2015
Vaccine Safety Report – An analysis of data & databases available to the Canadian Public by Nelle Maxey – March 2016
Vaccine Safety Report 3 – An analysis of 2016 Adverse Events Data & Databases by Nelle Maxey – June 2018
Review of the 2018 CAEFISS Summary Report by Nelle Maxey – October 2018
Vaccine Safety Report 7 – Protecting Vaccines or Protecting Children? By Nelle Maxey – February 2019
Further reading:
Nelle writes to the Canadian Health Minister:
Unexplained Delays in Canadian Vaccine Adverse Events Reporting – From February 2018
“Vaccine Choice Canada is deeply concerned that the public reporting of adverse events by both PHAC and MedEffect™ Canada are for unexplained reasons in hiatus. We appeal to you to look into this matter and explain why this hiatus has occurred as it directly affects the ability of the Canadian public to make informed decisions regarding vaccines.”